Project title: A diagnostic tool for accurate atheroma assessment to better manage vulnerable patients
QUT's Cardiovascular Engineering Laboratory is developing a diagnostic tool to better assess atheroma burden in patients with diabetes and cardiovascular disease.
Cardiovascular disease causes one in four deaths in Australia and adults with diabetes have a two- to three-fold increased risk of heart attacks and strokes. Spontaneous rupture and erosion of vulnerable atherosclerotic plaques are responsible for most acute vascular syndromes and many fatalities. However, there is no single technique currently available to accurately assess plaque vulnerability. Our team is developing a tool that can accurately diagnose and manage these vulnerable patients.
This project integrates the QUT team's extensive experience in developing image-based computational modelling techniques and established methodologies. Critical input from clinicians will guide the design of the software tool. The TTRA program funding will enable this project to develop a protype for testing in a clinical setting and advance towards a commercialisable diagnostic tool.
TTRA Project Round: One
- TTRA: $745,623
- Industry contribution: $20,000 cash, $509,500 in-kind
Duration: January 2022 – February 2024